Cancer Research

Solving The Cell: Will The Future Of Biology Be Boring?

learned all that we need to learn about this particular research model system? When should the community ...

Article - Michael White - Aug 11 2008 - 12:08pm

VELCADE(R) (Black Triangle Drug) (bortezomib) Approved For Previously Untreated Multiple Myeloma

(MM) is the second most common blood cancer, representing approximately one percent of all cancers and ...

Article - Anna Ohlden - Sep 8 2008 - 5:31am

UW Scientists Unlock Major Number Theory Puzzle

what Ramanujan did to us." Bringmann and Ono made sense of it all by finding a way to represent ...

Article - News Staff - Feb 28 2007 - 12:01am

Violent Sleep Disorder Linked To A Form Of Dementia

don’t exhibit symptoms of dementia, all patients we have seen with RBD do develop the pathology." ...

Article - News Staff - May 16 2007 - 7:45pm

RNA Polymerase II And P53 Work Together To Repair DNA Damage

damage happens all the time,” Ljungman says. “That puts pressure on cells to efficiently scan the DNA and ...

Article - News Staff - Sep 6 2007 - 11:03am

Study: Even Moderate Doses Of Methadone Can Kill

enabling a systematic study of all sudden cardiac arrests that occur in the Portland metropolitan area. ...

Article - News Staff - Jan 9 2008 - 2:18pm

Crowdsourcing Drug Development

Notebook Science is all about- getting feedback from those with expertise at the earliest possible moment. ...

Article - Jean-Claude Bradley - Jan 16 2008 - 6:03am

Stegography, Systems Biology And Computer Networks Find Common Mathematical Ground

almost all intergenic microRNA genes in four model species, human, mouse, rice and Arabidopsis, are ...

Article - News Staff - Mar 17 2008 - 12:48pm

Wellcome Trust Sanger Institute Reaches 1 Terabase, 300 Human Genomes In 6 Months

means that all genes and gene regions in many cancer samples can be looked at simultaneously. "We ...

Article - News Staff - Jul 1 2008 - 6:38pm

The National Cancer Institute Joins The Global Community Of Scientists Now Using BIOMARKERcenter From Thomson Reuters

conferences, clinical trial information, and other sources for all major therapeutic areas. For each therapy ...

Article - Anna Ohlden - Sep 4 2008 - 7:30am